Physitrack PLC · 1 day ago
Senior Account Executive (Enterprise - US)
Physitrack PLC is focused on elevating wellbeing through digital healthcare solutions. They are seeking a Senior Account Executive to lead complex sales cycles in the healthcare and workplace wellbeing sectors, engaging senior stakeholders and driving revenue growth.
Health CareRehabilitation
Responsibilities
Pipeline development across enterprise healthcare and workplace wellbeing accounts using outbound, events, partnerships, and referrals
Senior level discovery and consultative selling, including ROI modeling and business case development
End to end ownership of complex enterprise sales cycles from first engagement to contract signature
Close collaboration with internal teams to deliver client outcomes and retention
Representation of Physitrack at industry events, roundtables, and customer workshops
Qualification
Required
Five to eight years of B2B SaaS, digital health, or HR technology sales experience with a focus on enterprise accounts
Experience selling into the US healthcare sector is strongly valued, including insurers, providers, digital health platforms, or health systems
Proven success closing six figure and multi stakeholder deals in complex or regulated environments
Confidence engaging senior executives including c suite, clinical leaders, HR leaders, and procurement
Strong account planning, territory management, and forecasting discipline
Experience building ROI led business cases and multi year commercial agreements
High quality CRM hygiene (HubSpot) and pipeline management
Exceptional communication skills with the ability to translate clinical or technical concepts into clear business value
Preferred
HubSpot experience preferred
Benefits
Healthcare
401k
Twenty days PTO plus US public holidays
Paid sick leave up to forty hours per year
Full access to our leading wellbeing platform
Company
Physitrack PLC
Physitrack is a cloud-based patient engagement solution used by 80,000+ healthcare practitioners around the world with over 7M patients.
Funding
Current Stage
Public CompanyTotal Funding
$3.45MKey Investors
AlerisCrown Ocean Capital
2024-10-08Post Ipo Equity
2021-06-18IPO
2016-01-01Non Equity Assistance
Recent News
2025-12-11
2025-10-14
Company data provided by crunchbase